Extractables and Leachables Europe 2015, organised by Smithers Rapra, will be coming back to London, UK on 10-12 November in the heart of Bloomsbury.
Smithers Rapra’s E&L conferences are going from strength-to-strength, and following a highly successful US event with 130 attendees and an unprecedented number, last time the event was in London, this event leads the way in bringing together E&L experts from across the supply chain.
The event will once again provide delegates with a unique opportunity to come together to discuss all current E&L issues facing the pharmaceutical industry. The programme will feature the latest developments from industry practitioners and guidance from working groups to ensure the safe delivery of pharmaceuticals. Case studies of E&Ls in numerous drug-package combinations will also be presented, in addition to the latest information on regulatory updates, scientific based strategies and practical approaches for the evaluation of extractables and leachables for pharmaceutical packaging materials.
Smithers Rapra are now recruiting papers from experts and companies that have established best practice in the field of extractables and leachables. Organisations presenting a paper at this conference will have the opportunity to present to all parts of the pharmaceutical supply chain and will be firmly positioning themselves at the forefront of E&L activity. Submitted abstracts will be reviewed by the expert programme advisory board, consisting of E&L expert Dr Andrew Feilden at Smithers Rapra, and industry representatives Carsten Worsoe of Novo Nordisk, Dr Reinhard Stidl at Baxalta and Thomas Egert at Boehringer Ingelheim.
For more information or to submit a proposed paper title and short abstract, please contact Hayley Marsden, +44(0)1372 802026, firstname.lastname@example.org. The deadline for proposed papers is 30 June 2015.
The following topics will be particularly relevant to the direction of the conference, however all submitted themes will be considered:
- supply chain management;
- toxicology of possible leachables;
- single use systems;
- risk assessment methodologies relating to E&L strategies.
- application of E&L to QC testing programs;
- restricted and regulated substance compliance
- E&Ls and biologicals
- improvements in practical correlation of solvent extractions to product conditions of use
- E&Ls in process components and equipment
- Safety evaluations
- E&Ls and medical devices and combination products
- E&Ls in single-use-systems
- APIs and excipients